SMDAM
CLBT icon

Sumitomo Mitsui DS Asset Management’s Cellebrite CLBT Stock Holding History

Sumitomo Mitsui DS Asset Management’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-13,534
Closed -$186K – 772
2026
Q1 		$186K Buy
13,534
+1,318
+11% +$19.9K ﹤0.01% 753
2025
Q4 		$220K Buy
12,216
+1,850
+18% +$33.2K ﹤0.01% 744
2025
Q3 		$192K Buy
+10,366
New +$163K ﹤0.01% 741

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
MIF
Mediolanum International Funds Dublin 1, Ireland $11.7B AUM 47.18% 1-Year Est. Return
AWM
Apollon Wealth Management Mount Pleasant, South Carolina $8.23B AUM 30.88% 1-Year Est. Return
MNBTD
Moody National Bank Trust Division Galveston, Texas $1.21B AUM 38.93% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
HAM
Harmony Asset Management Scottsdale, Arizona $372M AUM 37.39% 1-Year Est. Return
HCA
Harbour Capital Advisors Tysons Corner, Virginia $549M AUM 54.99% 1-Year Est. Return

Sumitomo Mitsui DS Asset Management's CLBT Position: Q2 2026 in Review

Sumitomo Mitsui DS Asset Management sold out of Cellebrite (CLBT) in Q2 2026, closing a stake of 13,534 shares — an estimated $186K sold.

Sumitomo Mitsui DS Asset Management first reported a position in CLBT in Q3 2025 and held it in 3 quarters. The position peaked at $220K in Q4 2025. 29 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • Sumitomo Mitsui DS Asset Management reported no remaining Cellebrite position as of Q2 2026 after selling out during the quarter.
  • Sumitomo Mitsui DS Asset Management sold 13,534 Cellebrite shares in Q2 2026, an estimated $186K.
  • Sumitomo Mitsui DS Asset Management first reported a position in Cellebrite in Q3 2025 and held it in 3 quarters.
  • Sumitomo Mitsui DS Asset Management's Cellebrite position peaked at $220K in Q4 2025.
  • 29 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on Sumitomo Mitsui DS Asset Management's 13F filing for Q2 2026, filed 22 Jul 2026.